Related by context. All words. (Click for frequent words.) 75 teduglutide 68 NPSP# 68 PREOS 64 PROMACTA 64 NGX# 64 Marqibo 63 eltrombopag 63 Androxal 63 Gattex 63 FOLOTYN 63 pralatrexate 63 tamibarotene 63 hypoparathyroidism 62 Phenoptin 62 L MTP PE 62 alvimopan 62 lubiprostone 62 diabetic neuropathic pain 61 alvespimycin 61 vandetanib 61 Zerenex 61 pradefovir 61 eculizumab 61 tezampanel 61 Cimzia ® 61 phase IIa clinical 61 perifosine 61 elotuzumab 61 Fx #A 61 CoFactor 61 Amigal 61 picoplatin 61 Azedra 61 registrational 61 oral ridaforolimus 61 HuMax EGFr 61 elagolix 60 mipomersen 60 tivozanib 60 MoxDuo IR 60 GATTEX ® 60 Amrubicin 60 Dacogen injection 60 Nasulin 60 OPAXIO 60 blinatumomab 60 custirsen 60 sapacitabine 60 Phase IIa 60 pivotal Phase III 60 CIMZIA TM 60 BYDUREON 60 tanespimycin 60 Bronchitol 60 Fibrillex TM 60 LymphoStat B 60 TELINTRA 60 obatoclax 59 JAK inhibitor 59 denufosol 59 tafamidis 59 ONTAK 59 ozarelix 59 glufosfamide 59 Androxal ® 59 apremilast 59 PREOS R 59 tesamorelin 59 CIMZIA ™ 59 Traficet EN 59 PRT# 59 RDEA# 59 ruxolitinib 59 Phase 2b study 59 HuMax CD4 59 Targretin 59 Phase 1b clinical 59 Phase IIb clinical 59 Bicifadine 59 phase IIb clinical 59 valopicitabine 59 bicifadine 59 C1 INH 59 Vilazodone 59 lumiliximab 59 Triolex 59 ofatumumab 59 ADVEXIN 59 elacytarabine 59 Fampridine SR 59 Clolar 59 ZYBRESTAT fosbretabulin 59 decitabine 59 APF# 59 EOquin 59 Insegia 59 PXD# 59 ambrisentan 59 Increlex ® 59 TELCYTA 59 ataluren 59 XL# [003] 59 MultiStem 59 ularitide 59 Zelrix 59 forodesine 58 LEVADEX 58 placebo controlled clinical 58 pharmacokinetic profile 58 Ophena TM 58 cetrorelix 58 STELARA 58 celgosivir 58 Anturol 58 Dextofisopam 58 clofarabine 58 satraplatin 58 rNAPc2 58 RG# [001] 58 OncoVEX GM CSF 58 amrubicin 58 Evoltra 58 investigational drug 58 PS# [001] 58 MYDICAR ® 58 zanolimumab 58 TH# [003] 58 linaclotide 58 GATTEX TM 58 omacetaxine mepesuccinate 58 MGCD# [001] 58 Archexin 58 Ventavis 58 TOCOSOL Paclitaxel 58 non metastatic osteosarcoma 58 Gabapentin GR 58 teriflunomide 58 palonosetron 58 ACTEMRA 58 Topical Interferon Alpha 2b 58 R#/MEM # 58 Dacogen 58 Catena ® 58 ocrelizumab 58 Rebif ® 58 brentuximab vedotin 58 lurasidone 58 albinterferon alfa 2b 58 INCB# [001] 58 ZOLINZA 58 Entereg R 58 Serdaxin 58 Alzhemed TM 58 PEG PAL 58 SILENOR TM 58 AMR# 58 cinacalcet HCl 58 EFAPROXYN 58 ACTEMRA TM 58 Phase 2b trial 58 KNS # 58 relapsed multiple myeloma 58 orBec 58 velaglucerase alfa 58 ProSavin 58 TBC# 58 Restanza 58 AZILECT R 57 relapsed refractory multiple myeloma 57 Neurodex 57 RHUCIN 57 Tarceva TM 57 ganetespib 57 omacetaxine 57 Vidaza 57 telbivudine 57 azacitidine 57 enzastaurin 57 selective androgen receptor modulator 57 CR# vcMMAE 57 fidaxomicin 57 Adlea 57 Phase 2b clinical 57 FTY# 57 Phase III clinical 57 Phase Ib clinical 57 Nebido 57 HuMax CD# 57 subcutaneous formulation 57 AeroLEF TM 57 TG# [001] 57 atacicept 57 AGGRASTAT ® 57 Phase 1b 57 Icatibant 57 ostarine 57 romidepsin 57 BENLYSTA 57 FOLOTYN ® 57 GATTEX ™ 57 VPRIV 57 maribavir 57 eniluracil 57 ELND# 57 Preos 57 HuLuc# 57 Sym# 57 Zingo TM 57 Firazyr 57 otelixizumab 57 vilazodone 57 ISIS # 57 Empatic 57 IPLEX 57 Chemophase 57 SinuNase 57 KALBITOR 57 MAP# 57 peginesatide 57 ALKS 57 MabCampath 57 Allovectin 7 R 57 daclizumab 57 oxymorphone ER 57 dose cohorts 57 ecallantide 57 fenofibric acid 57 DAVANAT 57 Raptiva ® 57 Generx 57 thymalfasin 57 Cinryze TM 57 Phase Ib 57 INT# [002] 57 zileuton 57 adecatumumab 57 cannabinor 57 Androxal TM 57 Phase 2a trial 57 bazedoxifene 57 REMICADE ® 57 Phase IIa clinical 57 MAA submission 57 indiplon capsules 57 Rhucin 57 LEUKINE 57 LEVADEX ™ 57 Phase IIb 57 regadenoson 57 Ostarine 57 SNT MC# 57 HUMIRA 57 Corlux 57 Proxinium TM 57 Ceplene 57 Plenaxis TM 57 sorafenib tablets 57 Troxatyl 57 Tamibarotene 57 Phase 2b 57 HGS ETR1 57 pseudobulbar affect PBA 57 dextromethorphan quinidine 56 Evoltra ® 56 BLA submission 56 vernakalant oral 56 bosentan 56 ACAPODENE 56 PROVENGE 56 nab paclitaxel 56 Zenvia ™ 56 MONOVISC 56 Phase IIa trial 56 pexelizumab 56 QNEXA 56 dacetuzumab 56 ELADUR 56 CORLUX 56 ponatinib 56 sunitinib malate 56 KRN# 56 Numax 56 Panzem R NCD 56 TKM ApoB 56 DP b# 56 TEMODAL 56 Phase 1b trial 56 imetelstat 56 belinostat 56 RSD# 56 subcutaneously administered 56 JANUVIA 56 DR Cysteamine 56 AQ4N 56 TORISEL 56 axitinib 56 XGEVA 56 rFIXFc 56 Phase 2a 56 Amplimexon 56 Torisel 56 SEBIVO 56 Acetavance 56 YONDELIS 56 forodesine hydrochloride 56 IMGN# 56 ezogabine 56 MYDICAR 56 Naproxcinod 56 generation purine nucleoside 56 Cloretazine R VNP#M 56 CD# CEA 56 Reolysin 56 Sandostatin LAR 56 Dyloject TM 56 abiraterone acetate 56 Locteron 56 GAMMAGARD 56 COMFORT II 56 ATryn R 56 INCB# [002] 56 Surfaxin LS 56 dirucotide 56 exenatide once 56 efficacy tolerability 56 Phase IIa trials 56 PF # [001] 56 lintuzumab 56 arimoclomol 56 OMAPRO 56 BRIM2 56 Cimzia ® certolizumab pegol 56 ARIKACE 56 pharmacodynamic properties 56 TYKERB 56 TRISENOX 56 initiate Phase 1b 56 anticancer compound 56 baminercept 56 Chronic Idiopathic Constipation 56 Huntexil 56 confirmatory Phase III 56 oral prodrug 56 Nexavar ® 56 PHX# 56 REMINYL ® 56 PEG SN# 56 Pivotal Phase III 56 tecarfarin 56 HER2 positive metastatic breast 56 methylnaltrexone 56 Omigard 56 SAPHRIS 56 entinostat 56 Telintra 56 Trofex 56 PEG INTRON 56 KYNAPID 56 OHR/AVR# 56 Azilect ® 56 carfilzomib 56 Phase Ib study 56 evaluating REVLIMID 56 febuxostat 56 relapsed SCLC 56 opioid induced bowel dysfunction 56 Q#IR 56 rALLy clinical trial 56 visilizumab 56 vidofludimus 56 VELCADE melphalan 56 dimebon 56 CCX# B 56 Vicinium TM 56 CORT # 56 painful diabetic neuropathy 56 sBLA 56 L DOS# 56 Cleviprex TM clevidipine 56 treprostinil 56 nitazoxanide 56 rHuPH# 55 Azedra TM 55 Stedivaze 55 Aclasta 55 lixisenatide 55 panitumumab 55 Cladribine Tablets 55 INC# 55 Tavocept 55 Amitiza 55 Plicera 55 NP2 Enkephalin 55 PegIntron 55 Phase 1a clinical 55 Aurexis 55 azficel T 55 PLK1 SNALP 55 Bezielle 55 Zoraxel 55 Symadex 55 acyclovir Lauriad R 55 HspE7 55 rindopepimut 55 ILLUMINATE 55 urocortin 2 55 desvenlafaxine succinate 55 refractory APL 55 safinamide 55 cobiprostone 55 dose cohort 55 BEMA TM Fentanyl 55 deforolimus 55 oral FTY# 55 Asentar 55 ASA# 55 UPLYSO 55 Fludara 55 analgesic efficacy 55 phase IIb 55 Folotyn 55 ZYFLO 55 PRX# 55 GALNS 55 torezolid phosphate 55 AEGR 55 Soliris TM eculizumab 55 pomalidomide 55 XYOTAX 55 odanacatib 55 Clonicel 55 IMA# 55 Elagolix 55 AVN# [001] 55 pitavastatin 55 huC# DM4 55 RSD# oral 55 pirfenidone 55 RECOTHROM 55 romiplostim 55 favorable pharmacokinetic profile 55 INTEGRILIN 55 AP# [003] 55 cangrelor 55 refractory Hodgkin lymphoma 55 Junovan 55 vosaroxin 55 velafermin 55 tocilizumab 55 metaglidasen 55 APOPTONE 55 Relivar 55 talactoferrin 55 epratuzumab 55 ADX# 55 UVIDEM 55 Triapine R 55 davunetide 55 systemically administered 55 PRX # 55 BCX# 55 Zemplar Capsules 55 Zorbtive TM 55 HCD# [002] 55 RoACTEMRA 55 eprotirome 55 ThGRF 55 ZEVALIN 55 ILUVIEN ® 55 phase 2a 55 brivaracetam 55 reslizumab 55 AzaSite Plus 55 XL# XL# XL# 55 severe hypercholesterolemia 55 RSD# iv 55 FIRAZYR 55 AMITIZA 55 Phase 2a clinical 55 veltuzumab 55 ELACYT 55 SUTENT 55 ONGLYZA 55 ENBREL 55 PEG Interferon lambda 55 Rebif R 55 Augment Injectable 55 ToGA 55 ixabepilone 55 dosing cohort 55 NUEDEXTA 55 TYZEKA 55 Zavesca ® 55 NEBIDO 55 Mipomersen 55 DU #b 55 investigational compound 55 lymphoma CTCL 55 QUADRAMET 55 plus dexamethasone 55 LEP ETU 55 tgAAC# 55 Cimzia TM 55 ruboxistaurin 55 Ceflatonin 55 Jevtana 55 Mepact 55 adalimumab 55 Arcalyst 55 placebo controlled Phase 55 MBP# [001] 55 Phase IIb trial 55 PhosLo 55 Multaq R 55 Egrifta 55 INTERCEPT platelets 55 Locteron ® 55 Xanafide 55 PrevOnco ™ 55 EndoTAG TM -1 55 cladribine tablets 55 Contrave# 55 ARIKACE ™ 55 Nuvion 55 phase IIa 55 rhC1INH 55 Alpharadin 55 tipranavir 55 NTx TM -# 55 CA4P 55 alemtuzumab 55 voclosporin 55 epothilone 55 Soliris eculizumab 55 MERLIN TIMI 55 TASQ 55 XmAb# 55 Genasense 55 refractory gout 55 Emezine 55 registrational trial 55 PDE4 inhibitor 55 liposomal formulation 55 systemic immunosuppressive drugs 55 AEZS 55 Loramyc R 55 Capesaris 54 YERVOY 54 LibiGel ® 54 chlorambucil 54 lapatinib 54 BENLYSTA ® 54 Stelara 54 CANCIDAS 54 Golimumab 54 nalbuphine ER 54 alfimeprase 54 BAY #-# 54 lomitapide 54 Betaferon ® 54 CYT# 54 ZYBRESTAT 54 pain palliation 54 Ereska 54 AGGRASTAT R 54 Tracleer R 54 rhThrombin 54 Intermezzo R 54 lesinurad 54 VELCADE 54 E2F Decoy 54 Phase III pivotal 54 Reclast Aclasta 54 Taxotere R 54 Dual Opioid 54 incyclinide 54 pegloticase 54 tesmilifene 54 Aplidin 54 TREANDA 54 Phase IIB 54 mixed dyslipidemia 54 pharmacodynamic profile 54 COPEGUS 54 MyVax R 54 melphalan prednisone 54 metastatic renal cell carcinoma 54 Cotara 54 cutaneous T cell 54 Azixa 54 pharmacokinetic PK 54 BEMA Granisetron 54 RAPAFLO 54 fostamatinib 54 FAMPYRA 54 antitumor activity 54 Gemzar ® 54 Allovectin 7 ® 54 RH1 54 Certican 54 Glypromate 54 CYCLOSET 54 active comparator 54 DAVANAT R 54 Preotact 54 ALN RSV# 54 Clolar ® 54 #mg dose [001] 54 Pimavanserin 54 lorvotuzumab mertansine 54 Aclidinium 54 Cinryze ™ 54 ISTODAX 54 bardoxolone 54 Phase #/#a 54 toremifene 54 relapsing remitting multiple sclerosis 54 Kuvan 54 oral rivaroxaban 54 Kepivance 54 bavituximab 54 laquinimod 54 Oral NKTR 54 MACUGEN 54 ramelteon 54 ZACTIMA 54 inhaled liposomal ciprofloxacin 54 PEGINTRON 54 SCH # 54 LAF# 54 cariprazine 54 lintuzumab SGN 54 Frova ® 54 pharmacodynamic 54 confirmatory clinical 54 Rhucin ® 54 refractory PTCL 54 Northera 54 APD# 54 erlotinib 54 NPS NPS Pharmaceuticals 54 Chrysalin 54 Dapagliflozin 54 follicular NHL 54 Civacir 54 ALN TTR# 54 trospium 54 evaluating tivozanib 54 Onrigin 54 VIDAZA 54 Stimuvax 54 Cinryze 54 dabigatran etexilate 54 HGS ETR2 54 Pirfenidone 54 PrevOnco 54 CEQ# 54 CTAP# Capsules 54 PSMA ADC 54 chronic angina 54 Taxotere ® 54 intravenous acetaminophen 54 pegfilgrastim 54 Glybera 54 Acapodene 54 Virulizin R 54 sorafenib Nexavar 54 MIRCERA 54 Desmoteplase 54 Viramidine 54 lacosamide 54 myelodysplastic syndromes MDS 54 QAB# 54 RITUXAN 54 RLY# 54 vernakalant 54 aclidinium 54 rilonacept 54 sNDA 54 cilengitide 54 HEPLISAV 54 Tekamlo 54 Virulizin ® 54 Urocidin 54 GED aPC 54 Zenvia 54 telaprevir dosed 54 Exforge 54 adult chronic ITP 54 Lubiprostone 54 Promacta 54 postoperative ileus POI 54 metastatic HRPC 54 favorable tolerability 54 BARACLUDE R 54 RANK Ligand inhibitor 54 tolerability 54 Ceflatonin R 54 mGluR5 negative 54 CINOD 54 IIa trial 54 LY# [003] 54 Aloxi R 54 aflibercept VEGF Trap 54 bendamustine 54 MDV# 54 XL# anticancer compounds 54 Myocet 54 Riquent 54 bevirimat 54 Trofex TM 54 ascending dose 54 IV APAP 54 Imprime PGG 54 Clevudine 54 vismodegib 54 budesonide MMX 54 pharmacokinetics PK 54 EVIZON 54 PSN# [002] 54 EOquin TM 54 IRESSA 54 CTA# Injection 54 angiogenesis inhibitor 54 edoxaban 54 StaphVAX 54 IL# PE#QQR 54 preclinical studies 54 Phase III clinical trials 54 hoFH 54 GetGoal Phase III 54 PRADAXA 54 nilotinib 54 Phase Ib II 54 refractory multiple myeloma 54 varespladib 54 Ixempra 54 ALN PCS 53 virus HCV protease inhibitor 53 relapsing multiple sclerosis 53 Onbrez Breezhaler 53 Anturol TM 53 heterozygous FH 53 zalutumumab 53 Debio 53 THALOMID 53 clinical trials Multikine 53 ANA# 53 riociguat 53 Targretin capsules 53 Biologics License Application 53 CaPre TM 53 pharmacokinetic 53 NUVIGIL 53 MOZOBIL 53 mifamurtide 53 IDX# 53 Herceptin trastuzumab 53 Cethrin 53 rALLy trial 53 ONCASPAR 53 Phase III trials 53 SEROQUEL 53 diarrhea predominant irritable 53 Alocrest 53 CD# antibody [001] 53 RAPTIVA 53 cystinosis patients 53 GLP toxicology studies 53 EDEMA3 53 Ketotransdel 53 synthetic retinoid 53 Betaferon 53 Proellex TM 53 BEMA Fentanyl 53 Cellegesic 53 SANVAR 53 MLN# 53 Aeroquin 53 crizotinib PF # 53 ELIQUIS 53 tezampanel NGX# 53 HRPC 53 AVONEX ® 53 RhuDex ® 53 TRILIPIX 53 refractory chronic lymphocytic 53 hormone LHRH antagonist 53 Neuradiab 53 SPRYCEL 53 Nplate 53 ATryn ® 53 investigational monoclonal antibody 53 Tocosol Paclitaxel 53 briakinumab 53 Tyrima 53 RGB # 53 retigabine 53 multiple ascending dose 53 HepeX B 53 HoFH 53 Dyloject 53 bifeprunox 53 MEK inhibitor RDEA# 53 MAGE A3 ASCI 53 monotherapy 53 MAXY G# 53 Sandostatin LAR Depot 53 Factor VIIa 53 dasatinib 53 SYCREST 53 REYATAZ R 53 multicenter Phase III 53 Evoltra R 53 Phase III 53 GRN# 53 XP# XP# 53 Phase IIb trials 53 docetaxel Taxotere R 53 ospemifene 53 histamine dihydrochloride 53 ARCOXIA 53 bafetinib 53 Vandetanib 53 Fortigel 53 gefitinib Iressa 53 Azedra ™ 53 ALTU 53 AGILECT R 53 AEG# 53 ORENCIA ® 53 Sanvar R 53 TOLAMBA 53 Panzem 53 SIMPONI 53 Darusentan 53 L BLP# 53 interferon gamma 1b 53 Tovaxin 53 COPAXONE R 53 dose escalation trial 53 Vasovist 53 Ranexa 53 PROVENGE ® 53 Octreolin 53 metastatic RCC 53 Pixuvri 53 OMS#HP 53 ocular formulation 53 pivotal Phase 53 BNC# 53 Frova R 53 afatinib 53 pharmacodynamic PD 53 arzoxifene 53 oral Azacitidine 53 OncoGel 53 sargramostim 53 Tarceva erlotinib 53 oral Xeloda 53 refractory CLL 53 Ruconest 53 ThermoDox ® 53 ACZ# 53 Teysuno 53 omecamtiv mecarbil 53 Neulasta ® 53 T Pred 53 Nanobody 53 NVA# 53 GAMMAGARD LIQUID 53 budiodarone 53 PEGylated interferon beta 1a 53 MNTX 53 Onalta 53 vinorelbine 53 Emselex 53 PRISTIQ 53 Prodarsan ® 53 tasimelteon 53 ongoing Phase 1b 53 ONCONASE 53 roflumilast 53 GFT# 53 indacaterol 53 Orphan Drug designations 53 PEGPH# 53 CIMZIA TM certolizumab pegol 53 alemtuzumab Campath 53 BEXXAR 53 mg dose 53 atrasentan 53 Panzem R 53 AMITIZA R 53 Dalbavancin 53 adenosine injection 53 Hematide 53 post menopausal osteoporosis 53 Phenserine 53 Nabi HB Intravenous 53 volociximab 53 Entereg TM 53 Trizytek 53 ALD# 53 certolizumab 53 oral gallium 53 IRX 2 53 Leukine ® 53 rolofylline 53 Exelbine 53 Sanctura XR 53 neratinib 53 nonclinical studies 53 #mg/m# [001] 53 LIVALO 53 Xcytrin 53 telavancin 53 pazopanib 53 Increlex R 53 NU# [001] 53 Zenvia Phase III 53 asenapine 53 dacarbazine 53 faropenem 53 gefitinib 53 SomatoKine 53 Phase IIIb clinical 53 Treximet 53 mg doses 53 DDP# 53 fenofibrate 53 Quinamed 53 icatibant 53 pertuzumab 53 intermittent dosing 53 Acute Myeloid Leukemia AML 53 iclaprim 53 DPP4 inhibitor 53 Tarceva 53 ABSORB trial 53 telaprevir VX 53 naproxcinod 53 BrachySil TM 53 linagliptin 53 post herpetic neuralgia PHN 53 palifosfamide 53 TRANSDUR Sufentanil 53 aplindore 53 orally bioavailable 53 Daclizumab 53 preclinically 53 MabThera 53 Feraheme 53 catheter occlusion 53 miconazole Lauriad ® 53 vascular disrupting agent 53 Excellarate 53 safety tolerability pharmacokinetics 53 ® natalizumab 53 maximally tolerated dose 53 docetaxel 53 ridaforolimus 53 MGCD# [002] 53 NLX P# 53 ALGRX 53 TMC# [002] 53 Cimzia certolizumab pegol 53 posaconazole 53 tesetaxel 53 dosing cohorts 53 ZYFLO CR 53 ORENCIA R 53 Stimuvax R 53 Tezampanel 53 LCP AtorFen 53 Xcytrin R 53 GSK# [001] 53 Reverset 53 DAVANAT ® 53 dose limiting toxicities 53 chemotherapy induced neutropenia 53 DexaSite 53 CCX# 53 TroVax 53 chronic idiopathic thrombocytopenic purpura 53 terlipressin 53 ARCALYST 53 PLX PAD 53 Focalin XR 53 ABILIFY ® 53 TRIOLEX 53 IMiDs 53 EP #R 53 FIRMAGON R 53 Zenvia TM 52 alemtuzumab MS 52 HQK 52 TACI Ig 52 IBS C